![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RPL41 |
Gene summary for RPL41 |
![]() |
Gene information | Species | Human | Gene symbol | RPL41 | Gene ID | 6171 |
Gene name | ribosomal protein L41 | |
Gene Alias | L41 | |
Cytomap | 12q13.2 | |
Gene Type | protein-coding | GO ID | GO:0002181 | UniProtAcc | A0A024RB15 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
6171 | RPL41 | CA_HPV_2 | Human | Cervix | CC | 1.68e-30 | -2.39e-01 | 0.0391 |
6171 | RPL41 | CA_HPV_3 | Human | Cervix | CC | 3.01e-16 | -1.31e-01 | 0.0414 |
6171 | RPL41 | CCI_1 | Human | Cervix | CC | 4.40e-74 | -1.83e+00 | 0.528 |
6171 | RPL41 | CCI_2 | Human | Cervix | CC | 4.91e-32 | -9.70e-01 | 0.5249 |
6171 | RPL41 | CCI_3 | Human | Cervix | CC | 2.82e-90 | -1.98e+00 | 0.516 |
6171 | RPL41 | CCII_1 | Human | Cervix | CC | 2.65e-126 | -2.11e+00 | 0.3249 |
6171 | RPL41 | Tumor | Human | Cervix | CC | 2.20e-60 | -2.80e-01 | 0.1241 |
6171 | RPL41 | sample1 | Human | Cervix | CC | 1.69e-15 | -2.52e-01 | 0.0959 |
6171 | RPL41 | sample3 | Human | Cervix | CC | 8.35e-42 | -2.35e-01 | 0.1387 |
6171 | RPL41 | H2 | Human | Cervix | HSIL_HPV | 3.63e-65 | -4.11e-01 | 0.0632 |
6171 | RPL41 | L1 | Human | Cervix | CC | 3.65e-11 | -2.27e-01 | 0.0802 |
6171 | RPL41 | T1 | Human | Cervix | CC | 5.22e-49 | -3.63e-01 | 0.0918 |
6171 | RPL41 | T3 | Human | Cervix | CC | 9.08e-51 | -2.30e-01 | 0.1389 |
6171 | RPL41 | HTA11_3410_2000001011 | Human | Colorectum | AD | 8.00e-84 | 1.54e+00 | 0.0155 |
6171 | RPL41 | HTA11_2487_2000001011 | Human | Colorectum | SER | 5.72e-61 | 2.59e+00 | -0.1808 |
6171 | RPL41 | HTA11_2951_2000001011 | Human | Colorectum | AD | 2.33e-35 | 3.45e+00 | 0.0216 |
6171 | RPL41 | HTA11_1938_2000001011 | Human | Colorectum | AD | 4.97e-59 | 2.83e+00 | -0.0811 |
6171 | RPL41 | HTA11_78_2000001011 | Human | Colorectum | AD | 6.17e-24 | 1.03e+00 | -0.1088 |
6171 | RPL41 | HTA11_347_2000001011 | Human | Colorectum | AD | 2.29e-82 | 2.64e+00 | -0.1954 |
6171 | RPL41 | HTA11_411_2000001011 | Human | Colorectum | SER | 2.29e-24 | 3.17e+00 | -0.2602 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000218110 | Cervix | CC | cytoplasmic translation | 96/2311 | 148/18723 | 4.87e-51 | 2.91e-47 | 96 |
GO:000218115 | Cervix | HSIL_HPV | cytoplasmic translation | 86/737 | 148/18723 | 3.97e-82 | 1.91e-78 | 86 |
GO:0002181 | Colorectum | AD | cytoplasmic translation | 109/3918 | 148/18723 | 3.40e-43 | 2.13e-39 | 109 |
GO:00021811 | Colorectum | SER | cytoplasmic translation | 102/2897 | 148/18723 | 1.38e-48 | 8.49e-45 | 102 |
GO:00021812 | Colorectum | MSS | cytoplasmic translation | 108/3467 | 148/18723 | 1.78e-47 | 1.11e-43 | 108 |
GO:00021813 | Colorectum | MSI-H | cytoplasmic translation | 100/1319 | 148/18723 | 1.50e-79 | 8.31e-76 | 100 |
GO:00021814 | Colorectum | FAP | cytoplasmic translation | 76/2622 | 148/18723 | 3.31e-27 | 2.03e-23 | 76 |
GO:000218116 | Endometrium | AEH | cytoplasmic translation | 104/2100 | 148/18723 | 1.01e-64 | 6.07e-61 | 104 |
GO:000218117 | Endometrium | EEC | cytoplasmic translation | 104/2168 | 148/18723 | 2.53e-63 | 1.52e-59 | 104 |
GO:000218127 | Esophagus | HGIN | cytoplasmic translation | 108/2587 | 148/18723 | 1.70e-60 | 1.02e-56 | 108 |
GO:0002181111 | Esophagus | ESCC | cytoplasmic translation | 135/8552 | 148/18723 | 4.17e-32 | 2.65e-29 | 135 |
GO:00021817 | Liver | NAFLD | cytoplasmic translation | 93/1882 | 148/18723 | 1.44e-55 | 8.41e-52 | 93 |
GO:000218112 | Liver | Cirrhotic | cytoplasmic translation | 120/4634 | 148/18723 | 2.95e-47 | 1.85e-43 | 120 |
GO:000218122 | Liver | HCC | cytoplasmic translation | 132/7958 | 148/18723 | 9.09e-33 | 5.76e-30 | 132 |
GO:000218132 | Liver | Cyst | cytoplasmic translation | 70/496 | 148/18723 | 9.01e-71 | 3.85e-67 | 70 |
GO:000218120 | Oral cavity | OSCC | cytoplasmic translation | 133/7305 | 148/18723 | 1.94e-38 | 2.46e-35 | 133 |
GO:0002181110 | Oral cavity | LP | cytoplasmic translation | 124/4623 | 148/18723 | 5.09e-52 | 3.19e-48 | 124 |
GO:000218126 | Oral cavity | EOLP | cytoplasmic translation | 102/2218 | 148/18723 | 7.91e-60 | 4.74e-56 | 102 |
GO:000218134 | Oral cavity | NEOLP | cytoplasmic translation | 102/2005 | 148/18723 | 3.70e-64 | 2.20e-60 | 102 |
GO:000218118 | Prostate | BPH | cytoplasmic translation | 115/3107 | 148/18723 | 1.08e-60 | 6.68e-57 | 115 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0301030 | Oral cavity | OSCC | Ribosome | 128/3704 | 167/8465 | 2.42e-18 | 1.62e-16 | 8.25e-17 | 128 |
hsa0517130 | Oral cavity | OSCC | Coronavirus disease - COVID-19 | 156/3704 | 232/8465 | 2.30e-13 | 5.14e-12 | 2.62e-12 | 156 |
hsa03010114 | Oral cavity | OSCC | Ribosome | 128/3704 | 167/8465 | 2.42e-18 | 1.62e-16 | 8.25e-17 | 128 |
hsa05171114 | Oral cavity | OSCC | Coronavirus disease - COVID-19 | 156/3704 | 232/8465 | 2.30e-13 | 5.14e-12 | 2.62e-12 | 156 |
hsa03010210 | Oral cavity | LP | Ribosome | 127/2418 | 167/8465 | 1.22e-37 | 4.05e-35 | 2.61e-35 | 127 |
hsa05171210 | Oral cavity | LP | Coronavirus disease - COVID-19 | 128/2418 | 232/8465 | 7.04e-18 | 2.34e-16 | 1.51e-16 | 128 |
hsa0301038 | Oral cavity | LP | Ribosome | 127/2418 | 167/8465 | 1.22e-37 | 4.05e-35 | 2.61e-35 | 127 |
hsa0517138 | Oral cavity | LP | Coronavirus disease - COVID-19 | 128/2418 | 232/8465 | 7.04e-18 | 2.34e-16 | 1.51e-16 | 128 |
hsa0517146 | Oral cavity | EOLP | Coronavirus disease - COVID-19 | 108/1218 | 232/8465 | 8.08e-33 | 2.61e-30 | 1.54e-30 | 108 |
hsa0301046 | Oral cavity | EOLP | Ribosome | 81/1218 | 167/8465 | 2.63e-26 | 4.25e-24 | 2.51e-24 | 81 |
hsa0517156 | Oral cavity | EOLP | Coronavirus disease - COVID-19 | 108/1218 | 232/8465 | 8.08e-33 | 2.61e-30 | 1.54e-30 | 108 |
hsa0301056 | Oral cavity | EOLP | Ribosome | 81/1218 | 167/8465 | 2.63e-26 | 4.25e-24 | 2.51e-24 | 81 |
hsa0517164 | Oral cavity | NEOLP | Coronavirus disease - COVID-19 | 112/1112 | 232/8465 | 8.85e-40 | 2.82e-37 | 1.77e-37 | 112 |
hsa0301064 | Oral cavity | NEOLP | Ribosome | 81/1112 | 167/8465 | 4.35e-29 | 6.91e-27 | 4.35e-27 | 81 |
hsa0517174 | Oral cavity | NEOLP | Coronavirus disease - COVID-19 | 112/1112 | 232/8465 | 8.85e-40 | 2.82e-37 | 1.77e-37 | 112 |
hsa0301074 | Oral cavity | NEOLP | Ribosome | 81/1112 | 167/8465 | 4.35e-29 | 6.91e-27 | 4.35e-27 | 81 |
hsa0301028 | Prostate | BPH | Ribosome | 104/1718 | 167/8465 | 8.04e-33 | 1.33e-30 | 8.21e-31 | 104 |
hsa0517128 | Prostate | BPH | Coronavirus disease - COVID-19 | 115/1718 | 232/8465 | 5.65e-24 | 2.07e-22 | 1.28e-22 | 115 |
hsa03010113 | Prostate | BPH | Ribosome | 104/1718 | 167/8465 | 8.04e-33 | 1.33e-30 | 8.21e-31 | 104 |
hsa05171113 | Prostate | BPH | Coronavirus disease - COVID-19 | 115/1718 | 232/8465 | 5.65e-24 | 2.07e-22 | 1.28e-22 | 115 |
Page: 1 2 3 4 5 6 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RPL41 | SNV | Missense_Mutation | c.62N>C | p.Arg21Thr | p.R21T | P62945 | protein_coding | TCGA-B6-A0IJ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
RPL41 | SNV | Missense_Mutation | novel | c.53N>A | p.Arg18Lys | p.R18K | P62945 | protein_coding | TCGA-MY-A913-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | ||
RPL41 | SNV | Missense_Mutation | novel | c.57N>T | p.Lys19Asn | p.K19N | P62945 | protein_coding | TCGA-EY-A1G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
RPL41 | SNV | Missense_Mutation | novel | c.5N>C | p.Arg2Thr | p.R2T | P62945 | protein_coding | TCGA-NC-A5HG-01 | Lung | lung squamous cell carcinoma | Male | <65 | III/IV | Chemotherapy | cisplatin | CR |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |